Cargando…
Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II–III Rectal Cancer
Although rectal cancer comprises up to one-third of colorectal cancer cases and several prognosis nomograms have been established for colon cancer, statistical tools for predicting long-term survival in rectal cancer are lacking. In addition, previous prognostic studies did not include much imaging...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279662/ https://www.ncbi.nlm.nih.gov/pubmed/35847948 http://dx.doi.org/10.3389/fonc.2022.779030 |
_version_ | 1784746448179429376 |
---|---|
author | Nie, Ke Hu, Peng Zheng, Jianjun Zhang, Yang Yang, Pengfei Jabbour, Salma K. Yue, Ning Dong, Xue Xu, Shufeng Shen, Bo Niu, Tianye Hu, Xiaotong Cai, Xiujun Sun, Jihong |
author_facet | Nie, Ke Hu, Peng Zheng, Jianjun Zhang, Yang Yang, Pengfei Jabbour, Salma K. Yue, Ning Dong, Xue Xu, Shufeng Shen, Bo Niu, Tianye Hu, Xiaotong Cai, Xiujun Sun, Jihong |
author_sort | Nie, Ke |
collection | PubMed |
description | Although rectal cancer comprises up to one-third of colorectal cancer cases and several prognosis nomograms have been established for colon cancer, statistical tools for predicting long-term survival in rectal cancer are lacking. In addition, previous prognostic studies did not include much imaging findings, qualitatively or quantitatively. Therefore, we include multiparametric MRI information from both radiologists’ readings and quantitative radiomics signatures to construct a prognostic model that allows 5-year overall survival (OS) prediction for advance-staged rectal cancer patients. The result suggested that the model combined with quantitative imaging findings might outperform that of conventional TNM staging or other clinical prognostic factors. It was noteworthy that the identified radiomics signature consisted of three from dynamic contrast-enhanced (DCE)-MRI, four from anatomical MRI, and one from functional diffusion-weighted imaging (DWI). This highlighted the importance of multiparametric MRI to address the issue of long-term survival estimation in rectal cancer. Additionally, the constructed radiomics signature demonstrated value to the conventional prognostic factors in predicting 5-year OS for stage II–III rectal cancer. The presented nomogram also provides a practical example of individualized prognosis estimation and may potentially impact treatment strategies. |
format | Online Article Text |
id | pubmed-9279662 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92796622022-07-15 Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II–III Rectal Cancer Nie, Ke Hu, Peng Zheng, Jianjun Zhang, Yang Yang, Pengfei Jabbour, Salma K. Yue, Ning Dong, Xue Xu, Shufeng Shen, Bo Niu, Tianye Hu, Xiaotong Cai, Xiujun Sun, Jihong Front Oncol Oncology Although rectal cancer comprises up to one-third of colorectal cancer cases and several prognosis nomograms have been established for colon cancer, statistical tools for predicting long-term survival in rectal cancer are lacking. In addition, previous prognostic studies did not include much imaging findings, qualitatively or quantitatively. Therefore, we include multiparametric MRI information from both radiologists’ readings and quantitative radiomics signatures to construct a prognostic model that allows 5-year overall survival (OS) prediction for advance-staged rectal cancer patients. The result suggested that the model combined with quantitative imaging findings might outperform that of conventional TNM staging or other clinical prognostic factors. It was noteworthy that the identified radiomics signature consisted of three from dynamic contrast-enhanced (DCE)-MRI, four from anatomical MRI, and one from functional diffusion-weighted imaging (DWI). This highlighted the importance of multiparametric MRI to address the issue of long-term survival estimation in rectal cancer. Additionally, the constructed radiomics signature demonstrated value to the conventional prognostic factors in predicting 5-year OS for stage II–III rectal cancer. The presented nomogram also provides a practical example of individualized prognosis estimation and may potentially impact treatment strategies. Frontiers Media S.A. 2022-06-30 /pmc/articles/PMC9279662/ /pubmed/35847948 http://dx.doi.org/10.3389/fonc.2022.779030 Text en Copyright © 2022 Nie, Hu, Zheng, Zhang, Yang, Jabbour, Yue, Dong, Xu, Shen, Niu, Hu, Cai and Sun https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Nie, Ke Hu, Peng Zheng, Jianjun Zhang, Yang Yang, Pengfei Jabbour, Salma K. Yue, Ning Dong, Xue Xu, Shufeng Shen, Bo Niu, Tianye Hu, Xiaotong Cai, Xiujun Sun, Jihong Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II–III Rectal Cancer |
title | Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II–III Rectal Cancer |
title_full | Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II–III Rectal Cancer |
title_fullStr | Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II–III Rectal Cancer |
title_full_unstemmed | Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II–III Rectal Cancer |
title_short | Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II–III Rectal Cancer |
title_sort | incremental value of radiomics in 5-year overall survival prediction for stage ii–iii rectal cancer |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279662/ https://www.ncbi.nlm.nih.gov/pubmed/35847948 http://dx.doi.org/10.3389/fonc.2022.779030 |
work_keys_str_mv | AT nieke incrementalvalueofradiomicsin5yearoverallsurvivalpredictionforstageiiiiirectalcancer AT hupeng incrementalvalueofradiomicsin5yearoverallsurvivalpredictionforstageiiiiirectalcancer AT zhengjianjun incrementalvalueofradiomicsin5yearoverallsurvivalpredictionforstageiiiiirectalcancer AT zhangyang incrementalvalueofradiomicsin5yearoverallsurvivalpredictionforstageiiiiirectalcancer AT yangpengfei incrementalvalueofradiomicsin5yearoverallsurvivalpredictionforstageiiiiirectalcancer AT jabboursalmak incrementalvalueofradiomicsin5yearoverallsurvivalpredictionforstageiiiiirectalcancer AT yuening incrementalvalueofradiomicsin5yearoverallsurvivalpredictionforstageiiiiirectalcancer AT dongxue incrementalvalueofradiomicsin5yearoverallsurvivalpredictionforstageiiiiirectalcancer AT xushufeng incrementalvalueofradiomicsin5yearoverallsurvivalpredictionforstageiiiiirectalcancer AT shenbo incrementalvalueofradiomicsin5yearoverallsurvivalpredictionforstageiiiiirectalcancer AT niutianye incrementalvalueofradiomicsin5yearoverallsurvivalpredictionforstageiiiiirectalcancer AT huxiaotong incrementalvalueofradiomicsin5yearoverallsurvivalpredictionforstageiiiiirectalcancer AT caixiujun incrementalvalueofradiomicsin5yearoverallsurvivalpredictionforstageiiiiirectalcancer AT sunjihong incrementalvalueofradiomicsin5yearoverallsurvivalpredictionforstageiiiiirectalcancer |